The Latest Breaking News from Nasdaq

Here's a roundup of top developments in the biotech space over the last 24 hours:

Hive Blockchain Technologies (NASDAQ: HIVE), a company that mines Bitcoin (CRYPTO: BTC), Ethereum (CRYPTO: ETH) and other cryptocurrencies

Shares of crypto-related stocks, including Marathon Digital Holdings Inc (NASDAQ: MARA), HIVE Blockchain Technologies Ltd (NASDAQ: HIVE) and Coinbase Global, Inc. (NAS

On the legislative front of the psychedelics space, a new bill meant to study the therapeutic effects of psychedelic substances received full approval in both Utah chambers, standing out from among dozens of measures currently circulating in legislatures across several U.S. states. Psychedelic science also took an important step forward with the publication…

AN2 Therapeutics Inc filed plans on Friday to go public in an initial public offering in which it reportedly hopes to raise about $75 million. AN2 plans to list on the Nasdaq with the symbol of ANTX. The Menlo Park-based biotech is developing a therapy for non-tuberculous mycobacterial (NTM) lung disease, which…

    On Monday, 524 stocks hit new 52-week lows.

TherapeuticsMD Inc (NASDAQ:TXMD) has agreed to divest its VitaCare Prescription Services business to GoodRx Holdings Inc (NASDAQ:GDRX) for $150 million. VitaCare is a consumer-focused digital healthcare platform. TherapeuticsMD will also receive an additional $7 million in cash consideration contingent upon vitaCare's financial performance through 2023.  TXMD will also enter into a long-term services agreement to…

U.S. stocks traded lower midway through trading, with the Nasdaq dropping 250 points on Monday. The Secretary of State Antony Blinken said on Sunday that the United States and its allies are considering a ban on Russian oil and natural gas imports.

Shares of several companies in the broader technology sector, including Amazon.com, Inc. (NASDAQ: AMZN), Meta Platforms Inc (NASDAQ: FB) and Microsoft Corporation (NASDAQ: